Enumeration and characterization of viable tumor cells circulating in blood samples. Provides prognostic information and enables functional analysis of metastatic disease.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
NOROVA
China · 4 relevant products
Aliko Scientific SA
France · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
STRATEC/Diatron
Germany · 1 relevant product
Hangzhou Biotest Biotech Co., Ltd
China · 1 relevant product
Biopsense Oy
Finland · 4 relevant products
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Assure Tech. (Hangzhou) Co., Ltd.
China · 2 relevant products
Beijing SynsorBio Technology Co., Ltd
China · 1 relevant product
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 87 closest product alternatives
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Circulating Tumor Cell (CTC) detection products that identify and analyze tumor cells in patient blood samples. These products provide critical diagnostic information for cancer monitoring and treatment planning.
NOROVA · China
An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.
Aliko Scientific SA · France
Liquid biopsy platform designed to detect and analyze circulating tumor cells in patient samples. Enables non-invasive cancer monitoring and personalized medicine applications through advanced genetic testing.
guangzhou biotron technolongy co.,ltd · China
A next-generation circulating tumor cell detection system based on microfluidic chips and AI interpretation that captures cancer cells from a single blood sample. It enables non-invasive tumor monitoring, assists in lung nodule diagnosis, perioperative guidance, and treatment monitoring for precision oncology.
NOROVA · China
An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
Hangzhou Biotest Biotech Co., Ltd · China
A diagnostic test for detecting tumor markers in patient samples. This test is used in oncology screening and monitoring.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Diagnostic kits for detection and quantification of tumor-associated markers for oncology applications. Supports cancer screening, diagnosis, and treatment monitoring in clinical practice.
Assure Tech. (Hangzhou) Co., Ltd. · China
Quantitative and qualitative assays for detection of tumor-associated markers using immunoassay technology. Supports oncology screening and monitoring applications in clinical laboratories.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
75 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products